Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study

INTRODUCTION: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are believed to lower glucose levels and inhibit cardiovascular events related to type 2 diabetes (T2D). To maximize their benefits, the risk of resultant hypoglycemia has to be minimized; however, the magnitude of this risk remains unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Horii, Takeshi, Oikawa, Yoichi, Kunisada, Narumi, Shimada, Akira, Atsuda, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Emerging Technologies, Pharmacology and Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703042/
https://www.ncbi.nlm.nih.gov/pubmed/33246930
http://dx.doi.org/10.1136/bmjdrc-2020-001856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703042/
https://www.ncbi.nlm.nih.gov/pubmed/33246930
http://dx.doi.org/10.1136/bmjdrc-2020-001856

Ejemplares similares